Epigenomics - Articles and news items

FDA approves blood-based colorectal cancer screening test

Industry news / 13 April 2016 / Victoria White, Digital Content Producer

The FDA has approved Epigenomics’ lead product, Epi proColon, the first and only FDA-approved blood-based colorectal cancer screening test…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+